BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26473523)

  • 1. Evaluation of the Waters MassTrak LC-MS/MS Assay for Tacrolimus and a Comparison to the Abbott Architect Immunoassay.
    Saitman A; Metushi IG; Mason DS; Fitzgerald RL
    Ther Drug Monit; 2016 Jun; 38(3):300-4. PubMed ID: 26473523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Abbott ARCHITECT i2000 sirolimus assay and comparison with the Abbott IMx sirolimus assay and an established liquid chromatography-tandem mass spectrometry method.
    Johnson-Davis KL; De S; Jimenez E; McMillin GA; De BK
    Ther Drug Monit; 2011 Aug; 33(4):453-9. PubMed ID: 21743377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytical performance characteristics of the Abbott Architect i2000 Tacrolimus assay; comparisons with liquid chromatography-tandem mass spectrometry (LC-MS/MS) and Abbott IMx methods.
    De BK; Jimenez E; De S; Sawyer JC; McMillin GA
    Clin Chim Acta; 2009 Dec; 410(1-2):25-30. PubMed ID: 19751714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-site analytical evaluation of the Abbott ARCHITECT tacrolimus assay.
    Wallemacq P; Goffinet JS; O'Morchoe S; Rosiere T; Maine GT; Labalette M; Aimo G; Dickson D; Schmidt E; Schwinzer R; Schmid RW
    Ther Drug Monit; 2009 Apr; 31(2):198-204. PubMed ID: 19258928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of everolimus QMS immunoassay on Architect ci4100 and liquid chromatography/mass spectrometry: lack of agreement in organ-transplanted patients.
    Hoffer E; Kurnik D; Efrati E; Scherb I; Karasik M; Ring G; Bentur Y
    Ther Drug Monit; 2015 Apr; 37(2):214-9. PubMed ID: 25162218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Architect tacrolimus assay in kidney, liver, and heart transplant recipients.
    Bazin C; Guinedor A; Barau C; Gozalo C; Grimbert P; Duvoux C; Furlan V; Massias L; Hulin A
    J Pharm Biomed Anal; 2010 Dec; 53(4):997-1002. PubMed ID: 20674215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low plasma concentrations of albumin influence the affinity column-mediated immunoassay method for the measurement of tacrolimus in blood during the early period after liver transplantation.
    Tempestilli M; Di Stasio E; Basile MR; Elisei F; Antonini M; Ettorre GM; Iappelli M; Pucillo LP
    Ther Drug Monit; 2013 Feb; 35(1):96-100. PubMed ID: 23191996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of the Dimension TAC assay and comparison of multiple platforms for the measurement of tacrolimus.
    Cho EJ; Ko DH; Lee W; Chun S; Lee HK; Min WK
    J Clin Lab Anal; 2018 May; 32(4):e22357. PubMed ID: 29148096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two rapid ultra performance liquid chromatography/tandem mass spectrometry (UPLC/MS/MS) methods with common sample pretreatment for therapeutic drug monitoring of immunosuppressants compared to immunoassay.
    Tszyrsznic W; Borowiec A; Pawlowska E; Jazwiec R; Zochowska D; Bartlomiejczyk I; Zegarska J; Paczek L; Dadlez M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jun; 928():9-15. PubMed ID: 23584041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Everolimus method comparison between Waters MassTrak™ Immunosuppressants XE (IUO) kit and an in-house laboratory developed LC-MS/MS method in renal transplant patients.
    Johnson-Davis KL; Juenke JM; Thomas RL; Bradshaw T
    Ann Clin Lab Sci; 2015; 45(1):27-31. PubMed ID: 25696007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance Evaluation of a Restored Dimension TACR Assay: An Automated Platform for Measuring the Whole Blood Tacrolimus Concentration.
    Ko DH; Jeong TD; Lee W; Chun S; Min WK
    Clin Lab; 2016; 62(1-2):7-12. PubMed ID: 27012028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the New Siemens Tacrolimus Assay on the Dimension EXL Integrated Chemistry System Analyzer: Comparison With an Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Method.
    Bargnoux AS; Sutra T; Badiou S; Kuster N; Dupuy AM; Mourad G; Pageaux GP; Le Quintrec M; Cristol JP
    Ther Drug Monit; 2016 Dec; 38(6):808-812. PubMed ID: 27494947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardization of LC-MS for therapeutic drug monitoring of tacrolimus.
    Annesley TM; McKeown DA; Holt DW; Mussell C; Champarnaud E; Harter L; Calton LJ; Mason DS
    Clin Chem; 2013 Nov; 59(11):1630-7. PubMed ID: 23902823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of an LC-MS/MS method to measure tacrolimus in rat kidney and liver tissue and its application to human kidney biopsies.
    Noll BD; Coller JK; Somogyi AA; Morris RG; Russ GR; Hesselink DA; Van Gelder T; Sallustio BC
    Ther Drug Monit; 2013 Oct; 35(5):617-23. PubMed ID: 23921430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical Performance Evaluation of a New Cobas Tacrolimus Assay on Cobas e411 Analyzer: Comparison of Values Obtained by the CMIA Tacrolimus Assay and a Liquid Chromatography Combined with Tandem Mass Spectrometric Method.
    Dasgupta A; Khalil SA; Johnson-Davis KL
    Ann Clin Lab Sci; 2016; 46(2):204-8. PubMed ID: 27098629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and evaluation of a simulation procedure to take into account various assays for the Bayesian dose adjustment of tacrolimus.
    Saint-Marcoux F; Debord J; Parant F; Labalette M; Kamar N; Rostaing L; Rousseau A; Marquet P
    Ther Drug Monit; 2011 Apr; 33(2):171-7. PubMed ID: 21383655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of tacrolimus and three demethylated metabolites in human whole blood using LC-ESI-MS/MS.
    Dubbelboer IR; Pohanka A; Said R; Rosenborg S; Beck O
    Ther Drug Monit; 2012 Apr; 34(2):134-42. PubMed ID: 22406653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the automated Elecsys tacrolimus assay on the Roche cobas e 602 analyzer an acceptable replacement for a liquid chromatography-tandem mass spectrometry-based assay?
    Gant Kanegusuku A; Yeo KJ
    Am J Clin Pathol; 2024 Jan; 161(1):97-106. PubMed ID: 37724434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rapid, simple and sensitive liquid chromatography-tandem mass spectrometry method for routine clinical monitoring of tacrolimus with the Waters Masstrak™ immmunosuppressant kit.
    Guilhaumou R; Lacarelle B; Sampol-Manos E
    Methods Find Exp Clin Pharmacol; 2010 Dec; 32(10):737-43. PubMed ID: 21225010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of 2 immunoassays for monitoring low blood levels of tacrolimus.
    Amann S; Parker TS; Levine DM
    Ther Drug Monit; 2009 Apr; 31(2):273-6. PubMed ID: 19142177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.